EPO Patents = 1

Trademarks = 13

Forward Citations = 45

Loading Chart...

10 inventors (with patents filed for the assignee):

Brendan Mark Johnson (6 out of 12 patents)

Vijaykumar Reddy Rajasekhar (6 out of 17 patents)

Lynn Seely (4 out of 10 patents)

4. Paul N Mudd, Jr (4 out of 11 patents)

5. David B MacLean (3 out of 7 patents)

6. Laura Ann Williams (2 out of 4 patents)

7. Mark Hibberd (1 out of 3 patents)

8. Masataka Tanimoto (1 out of 3 patents)

9. Mayukh Vasant Sukhatme (1 out of 3 patents)

10. Susan Wollowitz (1 out of 36 patents)

11. Jr Paul N Mudd (0 patent)

6 patents: Sort by Forward Citations

1. 11638740 - Methods of treating female infertility (2023-05-02),

2. 11583526 - Treatment of prostate cancer (2023-02-21),

3. 11033551 - Methods of treating uterine fibroids (2021-06-15),

4. 11013780 - Methods of treating female infertility (2021-05-25),

5. 10786501 - Treatment of prostate cancer (2020-09-29),

6. 10449191 - Treatment of prostate cancer (2019-10-22),

Company Overview

Myovant Sciences is a healthcare company focused on developing and commercializing innovative therapies for women's health and prostate cancer. The company's lead product candidate, relugolix, has the potential to transform the treatment landscape for multiple hormone-sensitive conditions. Myovant is committed to improving the lives of patients through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#54 in Basel

#1,481 in Switzerland

Basel, Switzerland

Myovant Sciences Gmbh

Forward Citations = 45

10 inventors:

Brendan Mark Johnson (6 out of 12 patents)

Vijaykumar Reddy Rajasekhar (6 out of 17 patents)

Lynn Seely (4 out of 10 patents)

4. Paul N Mudd, Jr (4 out of 11 patents)

5. David B MacLean (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Myovant Sciences Gmbh. Retrieved from https://idiyas.com/company/myovant-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]